Eli Muchtar

7.7k total citations
176 papers, 2.8k citations indexed

About

Eli Muchtar is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Eli Muchtar has authored 176 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 92 papers in Hematology and 63 papers in Genetics. Recurrent topics in Eli Muchtar's work include Multiple Myeloma Research and Treatments (73 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (73 papers) and Chronic Lymphocytic Leukemia Research (44 papers). Eli Muchtar is often cited by papers focused on Multiple Myeloma Research and Treatments (73 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (73 papers) and Chronic Lymphocytic Leukemia Research (44 papers). Eli Muchtar collaborates with scholars based in United States, Israel and Saudi Arabia. Eli Muchtar's co-authors include Morie A. Gertz, Hila Magen, Angela Dispenzieri, Mical Paul, Leonard Leibovici, Galia Kariv, Vered Shani, Eyal Robenshtok, Francis K. Buadi and Shaji Kumar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Eli Muchtar

159 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eli Muchtar United States	27	1.3k	877	691	682	475	176	2.8k
Hyoung Jin Kang South Korea	27	600 0.4×	973 1.1×	582 0.8×	673 1.0×	323 0.7×	248	2.9k
Luciana Teofili Italy	30	1.0k 0.7×	1.1k 1.2×	896 1.3×	382 0.6×	152 0.3×	147	2.6k
Dick Stockelberg Sweden	22	741 0.5×	1.7k 2.0×	388 0.6×	763 1.1×	1.2k 2.5×	66	3.6k
Stefano Tarantolo United States	24	434 0.3×	1.1k 1.3×	266 0.4×	918 1.3×	1.1k 2.3×	79	3.3k
Christopher G. Winearls United Kingdom	30	1.1k 0.8×	758 0.9×	431 0.6×	162 0.2×	244 0.5×	83	3.6k
David E. Joyce United States	13	386 0.3×	741 0.8×	133 0.2×	121 0.2×	809 1.7×	20	2.0k
Arlene Reisman United States	17	755 0.6×	160 0.2×	127 0.2×	1.9k 2.7×	482 1.0×	54	3.6k
Junshik Hong South Korea	25	325 0.2×	354 0.4×	216 0.3×	685 1.0×	132 0.3×	179	2.0k
Bénédicte Lebrun‐Vignes France	30	400 0.3×	235 0.3×	478 0.7×	1.4k 2.1×	477 1.0×	120	3.9k
Ki‐Seong Eom South Korea	25	427 0.3×	1.5k 1.7×	317 0.5×	614 0.9×	242 0.5×	188	2.3k

Countries citing papers authored by Eli Muchtar

Since Specialization

Citations

This map shows the geographic impact of Eli Muchtar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Muchtar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Muchtar more than expected).

Fields of papers citing papers by Eli Muchtar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Muchtar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Muchtar. The network helps show where Eli Muchtar may publish in the future.

Co-authorship network of co-authors of Eli Muchtar

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Muchtar. A scholar is included among the top collaborators of Eli Muchtar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Muchtar. Eli Muchtar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Milone, Margherita, et al.. (2025). Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy–Associated Myopathies. Neurology. 105(7). e214101–e214101.

Vaxman, Iuliana, Shaji Kumar, Angela Dispenzieri, et al.. (2024). Autologous stem cell transplantation for multiple myeloma patients whose myeloma‐defining event was SLiM. British Journal of Haematology. 206(2). 607–614. 1 indexed citations

Hagen, Catherine E., Surendra Dasari, Jason D. Theis, et al.. (2023). Gastrointestinal amyloidosis: an often unexpected finding with systemic implications. Human Pathology. 139. 27–36. 6 indexed citations

Visram, Alissa, Suzanne R. Hayman, Angela Dispenzieri, et al.. (2023). A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL). American Journal of Hematology. 98(8). 1277–1285. 1 indexed citations

Visram, Alissa, S. Vincent Rajkumar, Prashant Kapoor, et al.. (2022). Second- and third-line treatment strategies in multiple myeloma: a referral-center experience. Blood Cancer Journal. 12(12). 164–164. 6 indexed citations

Saleh, Abdullah S. Al, M Hasib Sidiqi, Angela Dispenzieri, et al.. (2022). Treatment and outcomes of patients with light chain amyloidosis who received a second line of therapy post autologous stem cell transplantation. Blood Cancer Journal. 12(4). 59–59. 2 indexed citations

Visram, Alissa, Celine M. Vachon, Linda B. Baughn, et al.. (2021). Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis. Leukemia. 36(4). 1058–1065. 4 indexed citations

Ho, Matthew, Saurabh Zanwar, Prashant Kapoor, et al.. (2021). The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM). Blood Cancer Journal. 11(9). 158–158. 6 indexed citations

Saleh, Abdullah S. Al, Alissa Visram, Eli Muchtar, et al.. (2021). Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysis. Leukemia & lymphoma. 62(12). 3011–3018. 2 indexed citations

10.

Visram, Alissa, S. Vincent Rajkumar, Prashant Kapoor, et al.. (2021). Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis. Blood Cancer Journal. 11(11). 186–186. 16 indexed citations

11.

Parikh, Sameer A., Sara J. Achenbach, Timothy G. Call, et al.. (2020). The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice. Cancer Medicine. 9(10). 3390–3399. 39 indexed citations

12.

Sidana, Surbhi, Eli Muchtar, M Hasib Sidiqi, et al.. (2020). Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis. American Journal of Hematology. 95(5). 497–502. 32 indexed citations

13.

Vaxman, Iuliana, Alissa Visram, Shaji Kumar, et al.. (2020). Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents. Bone Marrow Transplantation. 56(5). 1144–1150. 12 indexed citations

14.

Hwa, Yi L., Martha Q. Lacy, Morie A. Gertz, et al.. (2020). Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide. European Journal Of Haematology. 106(3). 433–436. 2 indexed citations

15.

Saleh, Abdullah S. Al, M Hasib Sidiqi, Morie A. Gertz, et al.. (2019). Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma. American Journal of Hematology. 95(1). E8–E10. 12 indexed citations

16.

Saleh, Abdullah S. Al, M Hasib Sidiqi, Surbhi Sidana, et al.. (2019). Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis. American Journal of Hematology. 94(10). 1066–1071. 13 indexed citations

17.

Sidana, Surbhi, M Hasib Sidiqi, Angela Dispenzieri, et al.. (2019). Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis. American Journal of Hematology. 94(9). 1020–1026. 31 indexed citations

18.

Saleh, Abdullah S. Al, M Hasib Sidiqi, Angela Dispenzieri, et al.. (2019). Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients. American Journal of Hematology. 95(1). 4–9. 11 indexed citations

19.

Saleh, Abdullah S. Al, M Hasib Sidiqi, Eli Muchtar, et al.. (2019). Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved. Biology of Blood and Marrow Transplantation. 25(8). 1520–1525. 7 indexed citations

20.

Chakraborty, Rajshekhar, Eli Muchtar, Shaji Kumar, et al.. (2018). Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation. British Journal of Haematology. 182(1). 71–77. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact